TAI:4169
TCM Biotech International Corp. · TAI · Healthcare · TWD · FY for 2025
Figures on this page computed 2026-11-08 13:31 UTC
Last close
n/aTWD
Market data
357.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TWD
- computed
- Computed from the filing for 2025
1.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
2.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
5.3%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.04Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.3%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TWD
- computed
Price is the furthest below its sector's middle: 0.08 against 0.36 on the market's range.
Ten years as a story
lens 9 of 9We hold no filed year for this company, so there is nothing to read.
Nothing is drawn in its place. The other lenses are unaffected.